Related Experiment Videos

The ret/PTC oncogene in papillary thyroid carcinoma

S M Jhiang¹, E L Mazzaferri

¹Department of Internal Medicine, Ohio State University, Columbus.

The Journal of Laboratory and Clinical Medicine

|March 1, 1994

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Thyroid cancer epidemiology and prognostic variables.

Clinical oncology (Royal College of Radiologists (Great Britain))·2010

Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer?

Breast cancer research and treatment·2008

Genetic alterations in thyroid cancer: the role of mouse models.

Veterinary pathology·2007

Nasolacrimal obstruction secondary to I(131) therapy.

Ophthalmic plastic and reconstructive surgery·2004

Effects of dose, intervention time, and radionuclide on sodium iodide symporter (NIS)-targeted radionuclide therapy.

Gene therapy·2004

A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.

The Journal of clinical endocrinology and metabolism·2003

See all related articles